Literature DB >> 16511144

Crystallization and preliminary X-ray crystallographic analysis of adenosine 5'-monophosphate deaminase (AMPD) from Arabidopsis thaliana in complex with coformycin 5'-phosphate.

Byung Woo Han1, Craig A Bingman, Donna K Mahnke, Richard L Sabina, George N Phillips.   

Abstract

Adenosine 5'-monophosphate deaminase (AMPD) is a eukaryotic enzyme that converts adenosine 5'-monophosphate (AMP) to inosine 5'-monophosphate (IMP) and ammonia. AMPD from Arabidopsis thaliana (AtAMPD) was cloned into the baculoviral transfer vector p2Bac and co-transfected along with a modified baculoviral genome into Spodoptera frugiperda (Sf9) cells. The resulting recombinant baculovirus were plaque-purified, amplified and used to overexpress recombinant AtAMPD. Crystals of purified AtAMPD have been obtained to which coformycin 5'-phosphate, a transition-state inhibitor, is bound. Crystals belong to space group P6(2)22, with unit-cell parameters a = b = 131.325, c = 208.254 A, alpha = beta = 90, gamma = 120 degrees. Diffraction data were collected to 3.34 A resolution from a crystal in complex with coformycin 5'-phosphate and to 4.05 A resolution from a crystal of a mercury derivative.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511144      PMCID: PMC1952363          DOI: 10.1107/S1744309105019792

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  11 in total

1.  Localization of N-terminal sequences in human AMP deaminase isoforms that influence contractile protein binding.

Authors:  D K Mahnke-Zizelman; R L Sabina
Journal:  Biochem Biophys Res Commun       Date:  2001-07-13       Impact factor: 3.575

2.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

3.  Enzymatic catalysis and transition-state theory.

Authors:  G E Lienhard
Journal:  Science       Date:  1973-04-15       Impact factor: 47.728

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

5.  Isolation and characterization of AMP deaminase from mammalian (rabbit) myocardium.

Authors:  J K Thakkar; D R Janero; C Yarwood; H Sharif; D Hreniuk
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

6.  Catabolism of adenine nucleotides in suspension-cultured plant cells.

Authors:  N Yabuki; H Ashihara
Journal:  Biochim Biophys Acta       Date:  1991-04-09

Review 7.  Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms.

Authors:  R L Sabina; D K Mahnke-Zizelman
Journal:  Pharmacol Ther       Date:  2000 Aug-Sep       Impact factor: 12.310

8.  Expression, purification, and inhibition of in vitro proteolysis of human AMPD2 (isoform L) recombinant enzymes.

Authors:  Amy Louise Haas; Richard L Sabina
Journal:  Protein Expr Purif       Date:  2003-02       Impact factor: 1.650

9.  Properties of 5'-AMP deaminase and its inhibitors with the aid of a continuous fluorimetric assay with formycin-5'-phosphate as substrate.

Authors:  A Bzowska; D Shugar
Journal:  Z Naturforsch C J Biosci       Date:  1989 Jul-Aug

10.  Transition-state analysis of AMP deaminase.

Authors:  D J Merkler; P C Kline; P Weiss; V L Schramm
Journal:  Biochemistry       Date:  1993-12-07       Impact factor: 3.162

View more
  1 in total

1.  Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids.

Authors:  Christina Cicerchi; Nanxing Li; James Kratzer; Gabriela Garcia; Carlos A Roncal-Jimenez; Katsuyuki Tanabe; Brandi Hunter; Christopher J Rivard; Yuri Y Sautin; Eric A Gaucher; Richard J Johnson; Miguel A Lanaspa
Journal:  FASEB J       Date:  2014-04-22       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.